🔎 Trials Near Me

Home › Narcolepsy › Ohio

Narcolepsy clinical trials in Ohio

7 studies for Narcolepsy are looking for participants at sites in Ohio.

Cities in Ohio

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

  • Cincinnati, Ohio, Cincinnati
  • Dublin, Ohio, Dublin
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Sep 11, 2026 · NCT07598708

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

  • Alkermes Investigational Site, Cincinnati
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07455383

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

  • Intrepid Research, LLC, Cincinnati
  • The Cleveland Clinic Foundation, Cleveland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07675135

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

  • Intrepid Research, Cincinnati
  • Ohio Sleep Medicine and Neuroscience Institute, Dublin
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 19, 2026 · NCT07625280

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

  • Alkermes Investigational Site, Canton
  • Alkermes Investigational Site, Cincinnati
  • Alkermes Investigational Site, Cincinnati
  • and 1 more
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683

A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

  • Takeda Site 13, Cincinnati
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 29, 2026 · NCT07633301

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

  • Cincinnati, Ohio, Cincinnati
  • Dublin, Dublin
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.